The medical community is intrigued by retatrutide, a new dual GIP and GLP-1 agonist that’s showing remarkable results in early research. This compound works by mimicking natural hormones to regulate appetite and promote feelings of satiety, ultimately resulting in substantial fat loss . While still under investigation and not yet available, preli